亚太地区碳酸疗法市场预测至 2028 年 – COVID-19 影响和区域分析 – 按类型(台式、便携式等)、应用[美容医学(橘皮组织、妊娠纹、脱发和黑眼圈) )、皮肤科、妇科、血管科、骨科和风湿科、运动医学等]以及最终用户(医院、美容诊所和健康中心)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 109    |    Report Code: BMIRE00027978    |    Category: Life Sciences

Asia Pacific Carboxy Therapy Market

亚太地区羧基治疗市场预计将从2022年的2116万美元增长到2028年的4349万美元。预计2022年至2028年复合年增长率为12.8% .

 

羧基疗法应用领域的增加将在未来几年推动亚太地区羧基疗法市场

 

由于各种疾病的患病率不断增加,医疗保健行业正在不断显着发展。此外,人们意识的提高和美容标准的变化刺激了对美容和美容治疗的需求,从而增加了对各种设备和治疗的需求。当二氧化碳气体注入体内时,它会放松血管。它通过消除脂肪细胞来刺激特定区域的血液供应,这在美容和美学方面显示出了令人印象深刻的效果。这鼓励医疗保健专业人员尝试羧基疗法来治疗不同领域的各种疾病,例如妇科、神经病学、泌尿科和运动医学。例如,羧基疗法广泛用于治疗由血流量减少引起的阴道功能不全综合征。如今,勃起功能障碍也可以借助羧基疗法来治疗。此外,羧基疗法是一种负担得起的治疗选择,似乎安全有效,覆盖广泛的治疗领域,预计在不久的将来将进一步显着扩大。此外,羧基治疗应用领域的增加为羧基治疗设备制造商创造了充足的机会来开发和推出各种设备,这进一步有助于提供羧基治疗。因此,羧基治疗应用领域的增加、产品上市的激增以及羧基治疗设备的进一步创新预计将在预测期内促进亚太地区羧基治疗市场的增长。

 

亚太地区碳治疗市场概况

 

亚太地区羧基治疗市场分为中国、印度、日本、韩国、澳大利亚和亚太其他地区。该市场的推动因素包括中国和印度等国家人口众多、该地区市场参与者的关注度增加以及上述国家新产品或疗法的推出。微创面部美容手术(MIFCS)越来越受到中国年轻人的欢迎和接受,并影响着人们的方方面面。在中国,越来越多的年轻消费者,尤其是女性,正在寻找非侵入性美容选择,以立即可见的效果来改善外表。他们中的一些人会定期购买此类治疗方法。根据 2021 年 5 月发布的一项调查结果,约 7% 接受过非手术美容治疗的中国受访者表示,他们每月接受一次。另外 18.6% 的人每季度购买一次。据世界卫生组织称,中国是世界上老龄化人口增长最快的国家之一。 2019年,中国60岁及以上人口为2.54亿,65岁及以上人口为1.76亿。此外,由于预期寿命延长和生育率下降,预计到2040年,中国60岁以上人口比例将达到28%。因此,越来越多的老年人口选择羧基疗法进行整容手术,预计将在预测期内推动市场发展。

 

亚太地区二氧化碳治疗市场收入及 2028 年预测(百万美元)

亚太地区羧基治疗市场细分

 

亚太地区羧基治疗市场细分为以下类型:应用程序、最终用户和国家/地区。

根据类型,亚太地区羧基治疗市场分为台式、便携式和其他。预计到 2022 年,台式细分市场将占据最大的市场份额。

 

根据应用,亚太羧基治疗市场细分为美容医学、皮肤科、血管科、妇科、骨科和风湿科、运动医学等。预计到 2022 年,美容医学领域将占据最大的市场份额。美容医学领域进一步细分为脂肪团、妊娠纹、脱发和黑眼圈。

 

根据最终用户,亚太地区羧基疗法市场分为医院、美容诊所和健康中心。预计到 2022 年,医院细分市场将占据最大的市场份额。

 

根据国家/地区,亚太地区羧基治疗市场细分为澳大利亚、中国、印度、日本、韩国和亚太其他地区。 2022 年中国将占据市场份额。

 

Carbossiterapia Italiana; DTA 医疗;卡斯特纳-普拉西斯贝达夫; MBE 医疗部门;和 Mezopharma 是亚太地区羧基治疗市场的领先公司之一。



Asia Pacific Carboxy Therapy Strategic Insights

Strategic insights for Asia Pacific Carboxy Therapy involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-carboxy-therapy-market-strategic-framework.webp
Get more information on this report

Asia Pacific Carboxy Therapy Report Scope

Report Attribute Details
Market size in 2022 US$ 21.16 Million
Market Size by 2028 US$ 43.49 Million
Global CAGR (2022 - 2028) 12.8%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 类型
  • 台式
  • 便携式
By 应用
  • 美容医学
  • 皮肤科
  • 妇科
  • 血管科
  • 骨科及风湿病科
  • 运动医学
By 最终用户
  • 医院
  • 美容诊所
  • 健康中心
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Carbossiterapia Italiana
  • DTA Medical
  • Kastner-Praxisbedarf
  • MBE Medical Division
  • Mezopharma
  • Get more information on this report

    Asia Pacific Carboxy Therapy Regional Insights

    The regional scope of Asia Pacific Carboxy Therapy refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-carboxy-therapy-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Carboxy Therapy Market

    1. Carbossiterapia Italiana
    2. DTA Medical
    3. Kastner-Praxisbedarf
    4. MBE Medical Division    
    5. Mezopharma
    Frequently Asked Questions
    How big is the Asia Pacific Carboxy Therapy Market?

    The Asia Pacific Carboxy Therapy Market is valued at US$ 21.16 Million in 2022, it is projected to reach US$ 43.49 Million by 2028.

    What is the CAGR for Asia Pacific Carboxy Therapy Market by (2022 - 2028)?

    As per our report Asia Pacific Carboxy Therapy Market, the market size is valued at US$ 21.16 Million in 2022, projecting it to reach US$ 43.49 Million by 2028. This translates to a CAGR of approximately 12.8% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Carboxy Therapy Market report typically cover these key segments-

  • 类型 (台式, 便携式)
  • 应用 (美容医学, 皮肤科, 妇科, 血管科, 骨科及风湿病科, 运动医学)
  • 最终用户 (医院, 美容诊所, 健康中心)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Carboxy Therapy Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Carboxy Therapy Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in Asia Pacific Carboxy Therapy Market?

    The Asia Pacific Carboxy Therapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Carbossiterapia Italiana
  • DTA Medical
  • Kastner-Praxisbedarf
  • MBE Medical Division
  • Mezopharma
  • Who should buy this report?

    The Asia Pacific Carboxy Therapy Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Carboxy Therapy Market value chain can benefit from the information contained in a comprehensive market report.